Edmond T. FitzGerald

Davis Polk is advising Natura Cosméticos S.A. on its all-share acquisition of Avon Products, Inc. The transaction, which is expected to close in early 2020, is subject to customary closing…

Davis Polk is advising Nutrisystem, Inc. on its $1.4 billion acquisition by Tivity Health, Inc. The transaction, which is expected to close in the first quarter of 2019, is subject to…

Davis Polk is advising Tyson Foods, Inc. on its $2.16 billion acquisition of the Keystone Foods business from Marfrig Global Foods. The transaction, which is expected to close in mid-fiscal…

Davis Polk, together with Slaughter and May, is advising Shire plc in connection with a recommended cash and stock offer for Shire’s entire share capital by Takeda Pharmaceutical Company…

Davis Polk is advising Aetna on its approximately $77 billion acquisition by CVS Health. The transaction, which is expected to close in the second half of 2018, is subject to approval by…

Davis Polk is advising Deltic Timber Corporation on its definitive agreement to combine in an all-stock transaction with Potlatch Corporation. The combined company, which will be named…

Davis Polk is advising PharMerica Corporation on its approximately $1.4 billion acquisition by a newly formed company controlled by KKR, with Walgreens Boots Alliance, Inc. as a minority…

Davis Polk is advising Reckitt Benckiser Group plc on the sale of its Food Division to McCormick & Company Inc. for $4.2 billion in cash, subject to typical purchase price adjustments…

Davis Polk is advising Atairos Group, Inc. on its acquisition of a substantial ownership position in Bowlmor AMF from a group of previous investors led by Cerberus Capital Management, L.P…

Davis Polk is advising Tyson Foods, Inc. on its approximately $4.2 billion acquisition of AdvancePierre Foods Holdings, Inc. The transaction, which is expected to close in the third quarter…